UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

LncRNA FOXD2‐AS1 accelerates the papillary thyroid cancer progression through regulating the miR‐485‐5p/KLK7 axis

Journal of cellular biochemistry, 2019-05, Vol.120 (5), p.7952-7961

2019

Volltextzugriff (PDF)

Extracellular Domain of IL-10 Receptor Chain‑2 (IL-10R2) and Its Arginine-Containing Peptides Are Susceptible Substrates for Human Prostate Kallikrein‑2 (KLK2)

Biochemistry (Easton), 2024-08, Vol.63 (16), p.2023-2029

2024

Volltextzugriff (PDF)

MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10

Biochemical and biophysical research communications, 2018-09, Vol.503 (2), p.556-563

2018

Volltextzugriff (PDF)

EGR-1 acts as a transcriptional activator of KLK7 under IL-13 stimulation

Biochemical and biophysical research communications, 2021-01, Vol.534, p.303-309

2021

Volltextzugriff (PDF)

The host protease KLK5 primes and activates spike proteins to promote human betacoronavirus replication and lung inflammation

Science signaling, 2024-08, Vol.17 (850), p.eadn3785

2024

Volltextzugriff (PDF)

Deficiency of G protein‐coupled receptor Gpr111/Adgrf2 causes enamel hypomineralization in mice by alteration of the expression of kallikrein‐related peptidase 4 (Klk4) during pH cycling process

The FASEB journal, 2023-04, Vol.37 (4), p.e22861-n/a

2023

Volltextzugriff (PDF)

Systemic Inflammation Leads to Changes in the Intracellular Localization of KLK6 in Oligodendrocytes in Spinal Cord White Matter

Neurochemical research, 2023-09, Vol.48 (9), p.2645-2659

2023

Volltextzugriff (PDF)

Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker

International journal of molecular sciences, 2023-05, Vol.24 (9), p.8419

2023

Volltextzugriff (PDF)

Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2222

2024

Volltextzugriff (PDF)

Hypoxic Regulation of the KLK4 Gene in two Different Prostate Cancer Cells Treated with TGF- β

Cell biochemistry and biophysics, 2024-09, Vol.82 (3), p.2797-2812

2024

Volltextzugriff (PDF)

saKLK1-374 is more difficult to induce KLK1 expression in normal prostate cell lines than that in prostate cancer cell lines: Rethinking the universality of RNA activation

Biochemical and biophysical research communications, 2023-02, Vol.643, p.157-168

2023

Volltextzugriff (PDF)

Application of machine learning to large in vitro databases to identify drug–cancer cell interactions: azithromycin and KLK6 mutation status

Oncogene, 2021-05, Vol.40 (21), p.3766-3770

2021

Volltextzugriff (PDF)

Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC

Biochemical and biophysical research communications, 2018-05, Vol.499 (3), p.584-593

2018

Volltextzugriff (PDF)

A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering

The Journal of biological chemistry, 2018-08, Vol.293 (33), p.12663-12680

2018

Volltextzugriff (PDF)

Ablation of kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of high fat diet-induced obesity by counteracting adipose tissue inflammation in vivo

Cellular and molecular life sciences : CMLS, 2018-02, Vol.75 (4), p.727-742

2018

Volltextzugriff (PDF)

Elimination of KLK5 inhibits early skin tumorigenesis by reducing epidermal proteolysis and reinforcing epidermal microstructure

Biochimica et biophysica acta. Molecular basis of disease, 2019-11, Vol.1865 (11), p.165520, Article 165520

2019

Volltextzugriff (PDF)

KLK12 Regulates MMP-1 and MMP-9 via Bradykinin Receptors: Biomarkers for Differentiating Latent and Active Bovine Tuberculosis

International journal of molecular sciences, 2022-10, Vol.23 (20), p.12257

2022

Volltextzugriff (PDF)

NES1/KLK10 promotes trastuzumab resistance via activation of PI3K/AKT signaling pathway in gastric cancer

Journal of cellular biochemistry, 2018-08, Vol.119 (8), p.6398-6407

2018

Volltextzugriff (PDF)

Assessing the performance of docking, FEP, and MM/GBSA methods on a series of KLK6 inhibitors

Journal of computer-aided molecular design, 2023-09, Vol.37 (9), p.407-418

2023

Volltextzugriff (PDF)

KLK3 in the Regulation of Angiogenesis-Tumorigenic or Not?

International journal of molecular sciences, 2021-12, Vol.22 (24), p.13545

2021

Volltextzugriff (PDF)

MicroRNA-326 Inhibits Apoptosis and Promotes Proliferation of Dopaminergic Neurons in Parkinson’s Disease Through Suppression of KLK7-Mediated MAPK Signaling Pathway

Journal of molecular neuroscience, 2019-10, Vol.69 (2), p.197-214

2019

Volltextzugriff (PDF)

Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome

Molecular & cellular proteomics, 2019-05, Vol.18 (5), p.818-836

2019

Volltextzugriff (PDF)

KLK4T2 Is a Hormonally Regulated Transcript from the KLK4 Locus

International journal of molecular sciences, 2021-12, Vol.22 (23), p.13023

2021

Volltextzugriff (PDF)

Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients

Molecular medicine (Cambridge, Mass.), 2020-02, Vol.26 (1), p.19-19, Article 19

2020

Volltextzugriff (PDF)

KLK4 Inhibition by Cyclic and Acyclic Peptides: Structural and Dynamical Insights into Standard-Mechanism Protease Inhibitors

Biochemistry (Easton), 2019-05, Vol.58 (21), p.2524-2533

2019

Volltextzugriff (PDF)

1 – 25 von 2.206

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

ThemaBiochemistry & Molecular Biology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.135)
Mit Volltextzugriff
(1.986)

Publikationsform

Artikel
(2.169)
Buchkapitel
(35)
Bücher
(2)

Sprache

Englisch
(2.206)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.636)
EZB Electronic Journals Library
(1.172)
Ingenta
(1.112)
RCN full-text journals@Ovid
(717)
IngentaConnect Journals
(692)
Wiley-Blackwell Journals
(456)
Wiley Online Library
(365)
Springer journals
(297)
Standalone journals
(231)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(192)
Nature Journals Online
(190)
Access via ScienceDirect (Elsevier)
(171)
Nexis Uni
(162)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(152)
De Gruyter journals
(124)
Reference Global
(117)
Taylor & Francis
(81)
Taylor & Francis Journals
(80)
Oxford journals
(49)
Taylor & Francis Journals Complete
(42)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(30)

Menü

Weitere Dienste

Einstellungen

LncRNA FOXD2‐AS1 accelerates the papillary thyroid cancer progression through regulating the miR‐485‐5p/KLK7 axis

Extracellular Domain of IL-10 Receptor Chain‑2 (IL-10R2) and Its Arginine-Containing Peptides Are Susceptible Substrates for Human Prostate Kallikrein‑2 (KLK2)

MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10

EGR-1 acts as a transcriptional activator of KLK7 under IL-13 stimulation

The host protease KLK5 primes and activates spike proteins to promote human betacoronavirus replication and lung inflammation

Deficiency of G protein‐coupled receptor Gpr111/Adgrf2 causes enamel hypomineralization in mice by alteration of the expression of kallikrein‐related peptidase 4 (Klk4) during pH cycling process

Systemic Inflammation Leads to Changes in the Intracellular Localization of KLK6 in Oligodendrocytes in Spinal Cord White Matter

Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker

Genomic and Immunologic Correlates in Prostate Cancer with High Expression of KLK2

Hypoxic Regulation of the KLK4 Gene in two Different Prostate Cancer Cells Treated with TGF- β

saKLK1-374 is more difficult to induce KLK1 expression in normal prostate cell lines than that in prostate cancer cell lines: Rethinking the universality of RNA activation

Application of machine learning to large in vitro databases to identify drug–cancer cell interactions: azithromycin and KLK6 mutation status

Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC

A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering

Ablation of kallikrein 7 (KLK7) in adipose tissue ameliorates metabolic consequences of high fat diet-induced obesity by counteracting adipose tissue inflammation in vivo

Elimination of KLK5 inhibits early skin tumorigenesis by reducing epidermal proteolysis and reinforcing epidermal microstructure

KLK12 Regulates MMP-1 and MMP-9 via Bradykinin Receptors: Biomarkers for Differentiating Latent and Active Bovine Tuberculosis

NES1/KLK10 promotes trastuzumab resistance via activation of PI3K/AKT signaling pathway in gastric cancer

Assessing the performance of docking, FEP, and MM/GBSA methods on a series of KLK6 inhibitors

KLK3 in the Regulation of Angiogenesis-Tumorigenic or Not?

MicroRNA-326 Inhibits Apoptosis and Promotes Proliferation of Dopaminergic Neurons in Parkinson’s Disease Through Suppression of KLK7-Mediated MAPK Signaling Pathway

Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome

KLK4T2 Is a Hormonally Regulated Transcript from the KLK4 Locus

Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients

KLK4 Inhibition by Cyclic and Acyclic Peptides: Structural and Dynamical Insights into Standard-Mechanism Protease Inhibitors

Aktive Filter

Suchergebnisse filtern